Nühs A, De Rycker M, Manthri S, et al. Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity. PLoS Negl Trop Dis. 2015;9(9):e0004094. doi:10.1371/journal.pntd.0004094
Hempel CM, Sivula M, Levenson JM, et al. A system for performing high throughput assays of synaptic function. PLoS One. 2011;6(10):e25999. doi:10.1371/journal.pone.0025999
Lukens AK, Heidebrecht RW, Mulrooney C, et al. Diversity-oriented synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitors. J Infect Dis. 2015;211(7):1097-103. doi:10.1093/infdis/jiu565
Chan AI, McGregor LM, Jain T, Liu DR. Discovery of a Covalent Kinase Inhibitor from a DNA-Encoded Small-Molecule Library × Protein Library Selection. J Am Chem Soc. 2017;139(30):10192-10195. doi:10.1021/jacs.7b04880
Hyman SE. Revitalizing psychiatric therapeutics. Neuropsychopharmacology. 2014;39(1):220-9. doi:10.1038/npp.2013.181
Kennedy AL, Vallurupalli M, Chen L, et al. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma. Oncotarget. 2015;6(30):30178-93. doi:10.18632/oncotarget.4903
Lukens AK, Ross LS, Heidebrecht R, et al. Harnessing evolutionary fitness in Plasmodium falciparum for drug discovery and suppressing resistance. Proc Natl Acad Sci U S A. 2014;111(2):799-804. doi:10.1073/pnas.1320886110
MacRae CA, Peterson RT. Zebrafish as tools for drug discovery. Nat Rev Drug Discov. 2015;14(10):721-31. doi:10.1038/nrd4627
Akella LB, DeCaprio D. Cheminformatics approaches to analyze diversity in compound screening libraries. Curr Opin Chem Biol. 2010;14(3):325-30. doi:10.1016/j.cbpa.2010.03.017
Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506(7488):376-81. doi:10.1038/nature12873